naringenin has been researched along with Non-alcoholic Fatty Liver Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 8 (80.00) | 2.80 |
| Authors | Studies |
|---|---|
| Javad Hosseinzadeh-Attar, M; Mahdi Rezayat, S; Mansouri, S; Naeini, F; Namkhah, Z | 1 |
| Hosseinzadeh-Attar, MJ; Jazayeri-Tehrani, SA; Mansouri, S; Naeini, F; Namkhah, Z; Rezayat, SM; Tutunchi, H; Yaseri, M | 1 |
| Hosseinzadeh-Attar, MJ; Mansouri, S; Naeini, F; Namkhah, Z; Rezayat, SM; Tutunchi, H; Yaseri, M | 1 |
| Domínguez-Avila, JA; González-Aguilar, GA; López-Almada, G; Mejía-León, ME; Robles-Sánchez, M; Salazar-López, NJ | 1 |
| Han, D; Wang, F; Yu, C; Yu, J; Zhang, T; Zhu, C; Zhu, R | 1 |
| Hosseinzadeh-Attar, MJ; Naeini, F; Namkhah, Z; Ostadrahimi, A; Tutunchi, H | 1 |
| Anwaier, G; Hu, R; Liu, S; Qi, R; Shen, Q; Shen, W; Wang, Q | 1 |
| Hua, YQ; Xu, J; Xu, XL; Zeng, Y | 1 |
| Cao, W; Chen, S; Cheng, N; Liu, X; Zhao, H | 1 |
| Ben Slima, A; Chtourou, Y; Fetoui, H; Gdoura, R; Jemai, R; Makni, M | 1 |
2 review(s) available for naringenin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Could Naringenin Participate as a Regulator of Obesity and Satiety?
Topics: Diabetes Mellitus, Type 2; Flavanones; Humans; Inflammation; Insulin Resistance; Non-alcoholic Fatty Liver Disease; Obesity | 2023 |
A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
Topics: Citrus; Flavanones; Flavonoids; Humans; Non-alcoholic Fatty Liver Disease; Risk Factors | 2021 |
3 trial(s) available for naringenin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial.
Topics: Dietary Supplements; Double-Blind Method; Flavanones; Humans; Iran; Lipids; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Probability | 2021 |
Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
Topics: Dietary Supplements; Double-Blind Method; Flavanones; Humans; Iran; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Randomized Controlled Trials as Topic | 2021 |
Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.
Topics: Cardiovascular Diseases; Dietary Supplements; Double-Blind Method; Flavanones; Heart Disease Risk Factors; Humans; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Risk Factors | 2022 |
5 other study(ies) available for naringenin and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Exploration of potential targets and mechanisms of naringenin in the treatment of nonalcoholic fatty liver disease through network pharmacology.
Topics: Drugs, Chinese Herbal; Flavanones; Humans; Medicine, Chinese Traditional; MicroRNAs; Network Pharmacology; Non-alcoholic Fatty Liver Disease | 2023 |
Formulation and intestinal absorption of naringenin loaded nanostructured lipid carrier and its inhibitory effects on nonalcoholic fatty liver disease.
Topics: Animals; Biological Transport; Dogs; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Epithelial Cells; Flavanones; Intestinal Absorption; Lipids; Liver; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Nanostructures; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; Temperature | 2021 |
Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe
Topics: Animals; Flavanones; Lipid Metabolism; Liver; Liver Cirrhosis; Male; Mice, Inbred C57BL; Mice, Knockout, ApoE; NF-kappa B; Non-alcoholic Fatty Liver Disease; Nuclear Proteins; Oxidative Stress; Reactive Oxygen Species; Sirtuin 1; Transcription Factors | 2021 |
Impact of SchisandraChinensis Bee Pollen on Nonalcoholic Fatty Liver Disease and Gut Microbiota in HighFat Diet Induced Obese Mice.
Topics: Animals; Bees; Diet, High-Fat; Disease Models, Animal; Flavanones; Flavonoids; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Pollen; Rutin; Schisandra | 2019 |
Naringenin reduces cholesterol-induced hepatic inflammation in rats by modulating matrix metalloproteinases-2, 9 via inhibition of nuclear factor κB pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Body Weight; Cholesterol; DNA Fragmentation; Down-Regulation; Flavanones; Inflammation Mediators; Lipids; Liver; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Signal Transduction | 2015 |